Attached files
file | filename |
---|---|
10-Q - Sonoma Pharmaceuticals, Inc. | v192572_10q.htm |
EX-31.2 - Sonoma Pharmaceuticals, Inc. | v192572_ex31-2.htm |
EX-31.1 - Sonoma Pharmaceuticals, Inc. | v192572_ex31-1.htm |
EX-10.34 - Sonoma Pharmaceuticals, Inc. | v192572_ex10-34.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
(18
U.S.C. SECTION 1350)
Pursuant
to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
section 1350, chapter 63 of title 18, United States Code), the undersigned
officers of Oculus Innovative Sciences, Inc., a Delaware corporation (the
“Company”), do hereby certify, to such officers’ knowledge, that:
The
Quarterly Report on Form 10-Q for the quarter ended June 30, 2010 (the “Form
10-Q”) of the Company fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, and the information contained in
the Form 10-Q fairly presents, in all material respects, the financial condition
and results of operations of the Company.
Date:
August 5, 2010
|
By:
|
/s/ Hojabr Alimi
|
Hojabr
Alimi
|
||
Chief
Executive Officer
|
||
Date:
August 5, 2010
|
By:
|
/s/ Robert Miller
|
Robert
Miller
|
||
Chief
Financial Officer
|